
HS-1371
CAS No. 2158197-70-5
HS-1371 ( HS1371 | HS 1371 )
产品货号. M13442 CAS No. 2158197-70-5
HS-1371 (HS1371) 是一种新型有效的 ATP 竞争性受体相互作用蛋白激酶 3(RIP3 或 RIPK3 激酶)抑制剂,IC50 为 20.8 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
![]() ![]() |
10MG | ¥1369 | 有现货 |
![]() ![]() |
25MG | ¥2859 | 有现货 |
![]() ![]() |
50MG | ¥4358 | 有现货 |
![]() ![]() |
100MG | ¥6294 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称HS-1371
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述HS-1371 (HS1371) 是一种新型有效的 ATP 竞争性受体相互作用蛋白激酶 3(RIP3 或 RIPK3 激酶)抑制剂,IC50 为 20.8 nM。
-
产品描述HS-1371 (HS1371) is a novel potent, ATP-competitive receptor-interacting protein kinase-3 (RIP3 or RIPK3 kinase) inhibitor with IC50 of 20.8 nM; binds to the ATP binding pocket of RIP3 and inhibits ATP binding to prevent RIP3 enzymatic activity in vitro; inhibits S227 auto-phosphorylation of RIP3 in treated HT-29 cells, blocks necrosome complex formation, rescues cells from RIP3-dependent necroptotic cell death but not apoptotic cell death.
-
体外实验HS-1371 directly binds to RIP3 in an ATP-competitive and time-independent manner. HS-1371 has an inhibitory effect on RIP3 kinase activity in various cell lines.HS-1371 (0.1, 1, 5, 10, 20 μM, 9 h) can block RIP3 S227 phosphorylation.HS-1371(0.1, 1, 5, 10 μM, 24 h) rescues cells from RIP3-dependent necroptotic cell death but not apoptotic cell death. Western Blot AnalysisCell Line:HT-29 cells?Concentration:0.1, 1, 5, 10, 20 μM Incubation Time:9 hours Result:Showed an inhibitory effect on S227 auto-phosphorylation of RIP3.
-
体内实验——
-
同义词HS1371 | HS 1371
-
通路Apoptosis
-
靶点RIP kinase
-
受体RIP kinase
-
研究领域——
-
适应症——
化学信息
-
CAS Number2158197-70-5
-
分子量384.483
-
分子式C24H24N4O
-
纯度>98% (HPLC)
-
溶解度DMSO : 16.67 mg/mL 43.36 mM
-
SMILESCC1=CC=C(OC2=CC=NC3=CC(C4=CN(C5CCNCC5)N=C4)=CC=C23)C=C1
-
化学全称7-(1-(Piperidin-4-yl)-1H-pyrazol-4-yl)-4-(p-tolyloxy)quinoline
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Park HH, et al. Exp Mol Med. 2018 Sep 20;50(9):125.
产品手册




关联产品
-
GSK-583
一种有效的、选择性的、口服生物可利用的 RIPK2 激酶抑制剂,对人和大鼠 RIP2 的 IC50 分别为 5 nM 和 2 nM。
-
Necrostatin 2
Necrostatin 2 是一种有效的程序性坏死 (necroptosis) 抑制剂。作用于TNF-α处理的FADD缺陷型Jurkat T细胞,抑制程序性坏死,EC50 为 0.05 μM。Necrostatin 2 为 RIPK1 抑制剂。
-
GSK840
GSK840 是一种受体相互作用蛋白激酶 3(RIP3 或 RIPK3)抑制剂,可结合 RIP3 激酶结构域 (IC50: 0.9 nM),并抑制激酶活性 (IC50: 0.3 nM)。